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Abstract
Background:  For individuals with AIDS, data exist relatively soon after diagnosis to allow
estimation of "early" survival quantiles (e.g., the 0.10, 0.15, 0.20 and 0.30 quantiles, etc.). Many years
of additional observation must elapse before median survival, a summary measure of survival, can
be estimated accurately. In this study, a new approach to predict AIDS median survival is presented
and its accuracy tested using AIDS surveillance data.
Methods: The data consisted of 96,373 individuals who were reported to the HIV/AIDS Reporting
System of the California Department of Health Services Office of AIDS as of December 31, 1996.
We defined cohorts based on quarter year of diagnosis (e.g., the "931" cohort consists of individuals
diagnosed with AIDS in the first quarter of 1993). We used early quantiles (estimated using the
Inverse Probability of Censoring Weighted estimator) of the survival distribution to estimate
median survival by assuming a linear relationship between the earlier quantiles and median survival.
From this model, median survival was predicted for cohorts for which a median could not be
estimated empirically from the available data. This prediction was compared with the actual
medians observed when using updated survival data reported at least five years later.
Results: Using the 0.15 quantile as the predictor and the data available as of December 31, 1996,
we were able to predict the median survival of four cohorts (933, 934, 941, and 942) to be 34, 34,
31, and 29 months. Without this approach, there were insufficient data with which to make any
estimate of median survival. The actual median survival of these four cohorts (using data as of
December 31, 2001) was found to be 32, 40, 46, and 80 months, suggesting that the accuracy for
this approach requires a minimum of three years to elapse from diagnosis to the time an accurate
prediction can be made.
Conclusion: The results of this study suggest that early and accurate prediction of median survival
time after AIDS diagnosis may be possible using early quantiles of the survival distribution. The
methodology did not seem to work well during a period of significant change in survival as observed
with highly active antiretroviral treatment, but results suggest that it may work well in a time of
more gradual improvement in survival.
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Background
Since the beginning of the AIDS epidemic, the prediction
of trends in survival after an AIDS diagnosis has been
important for planning health care services and for moni-
toring the impact of the epidemic. Temporal associations
between improved survival following the introduction of
expanded treatment options provide population-based
evidence that there may be beneficial treatment effects
long before these hypotheses can be tested formally. In a
time when health care resources are limited and health
priorities must be established, it is crucial to project the
short-term mortality after AIDS for future planning of
health care resources [1].
Temporal trends and improvements in survival with AIDS
were reported early in the epidemic even before the intro-
duction of advances in therapy [2]. Shortly after the intro-
duction of zidovudine therapy, temporal trends in
survival were (eventually) noted using surveillance data
[3]. Other registry-based studies investigated the relation-
ship between survival following an AIDS diagnosis and
calendar date of diagnosis [4,5]. These studies consistently
showed marked improvements in AIDS survival after the
introduction of zidovudine therapy and Pneumocystis cari-
nii pneumonia prophylaxis. More recently, the introduc-
tion of highly active antiretroviral therapy (HAART) has
renewed the idea of examining trends in survival after an
AIDS diagnosis in order to study both the short- and long-
term effects of these new drugs on HIV-related morbidity
and mortality.
In this study, a new approach was implemented to predict
AIDS survival and test its accuracy using AIDS surveillance
data. The purpose of this study was: (1) to determine the
earliest quantile (such as 0.10, 0.15, or 0.20) of the sur-
vival distribution that can be used to predict accurately a
cohort's subsequently observed median survival, and (2)
to estimate the survival quantiles using the Inverse Proba-
bility of Censoring Weighted (IPCW) estimator [6] in
order to improve the prediction methodology in the com-
mon situation with registry data in which death is subject
to delays in reporting [7].
For cohorts of individuals who have recently been diag-
nosed with AIDS, data exist for "early" survival quantiles
(such as the 0.10, 0.15, 0.20 quantiles, etc.) but many
years of additional observation must elapse before later
quantiles, such as the median (0.50 quantile) can be esti-
mated with accuracy. Assuming a linear relationship
between the early survival quantile and the median sur-
vival, an early prediction of the median value for a
cohort's eventual survival distribution is compared to the
actual or true median value for the cohort. If the predicted
median is accurate, then early estimation of AIDS survival
is possible and will be of great benefit to health care plan-
ners developing strategies and financing for the health
care needs of these patients. Additionally, such an accu-
rate, early prediction methodology could be extended to
other large, population-based surveillance systems where
survival prediction is a major goal.
Methods
California AIDS surveillance data
The California Department of Health Services, Office of
AIDS (OA), in cooperation with the Centers for Disease
Control and Prevention (CDC), maintains a registry of all
reports of AIDS cases in California. This registry, the HIV/
AIDS Reporting System (HARS), contains demographic,
risk factor and limited clinical information on each
reported case. A HARS data set as of December 31, 2001
was used to obtain four variables: the dates of AIDS diag-
nosis (month and year only; the day was assumed to be 15
in order to calculate a date), the dates of death (if
reported), the dates the deaths were reported to the CDC,
and the date each case was entered into the registry. Dates
of death are updated periodically by local city and county
health departments and by OA using the California Death
Registry and the National Death Index.
The State of California Health and Human Services
Agency Committee for the Protection of Human Subjects
and the Committee for the Protection of Human Subjects
at the University of California at Berkeley approved the
use of these data for this purpose.
Identification of cohorts of AIDS patients as of December 
31, 1996
The date of AIDS diagnosis is the date of the first condi-
tion that would allow a person to be classified as having
AIDS under the 1993 change in the AIDS case definition
[8]. This definition was retroactively applied to cases diag-
nosed prior to 1993. Cases were grouped into cohorts
defined by the calendar quarter of their AIDS diagnosis.
For example, a person diagnosed in November of 1992
(i.e., the fourth quarter of 1992) was classified into the
"924" cohort. All AIDS cases diagnosed according to the
1993 change in the AIDS case definition and entered into
the HARS Registry between January 1, 1983 and Decem-
ber 31, 1996 were eligible to be included in the study.
Determination of survival from AIDS diagnosis to death
CDC receives information from California's HIV/AIDS
Registry on a monthly basis. For all newly-reported
deaths, the date on which the death was first reported to
the CDC is recorded. In order to re-create the death infor-
mation that would have been available to any investigator
as of December 31, 1996, death dates were included only
if they were reported on or before this date. Survival time
was defined as the time elapsed from the date of the AIDSBMC Public Health 2007, 7:127 http://www.biomedcentral.com/1471-2458/7/127
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diagnosis until death from all causes, or until December
31, 1996, the date of analysis for the study.
The Inverse Probability of Censoring Weighted estimator
For many sources of registry-based data, there is a delay
between the recording of vital status and its availability for
analysis. In such situations, the analyst may assume mis-
takenly that those who are not yet known to have died are
still alive when, in fact, some of these individuals may
have died but the deaths have not yet been reported to the
registry. The use of the Kaplan-Meier (K-M) estimator to
estimate survival in this situation has been shown to be
inconsistent and to yield biased results [9]. Following the
approach of Robins and Rotnitzky [10], van der Laan and
Hubbard [6] and Hubbard et al. [11] proposed a simple
inverse probability of censoring weighted estimator to
account for this delay in vital status information and this
estimator was applied in this study.
The study sample consists of 56 cohorts of individuals
with AIDS defined by the quarter year of diagnosis. Since
the censoring date (the date of analysis) is December 31,
1996, individuals diagnosed with AIDS in the 951 cohort
who survived the entire period can only have censoring
times equal to 23 months (for those diagnosed in Janu-
ary), 22 months (for those diagnosed in February), or 21
months (for those diagnosed in March). One possible
concern with using the IPCW estimator to estimate the
survival distribution is that the estimator may perform
poorly if the censoring distribution has all of its weight on
a small set of times, as observed with this data. If there are
subjects for whom the reporting time is greater than the
support of possible censoring times, the IPCW may be
biased [11]. In order to account for this, artificial censor-
ing was used to augment the estimator.
Each case was assigned a new, uniformly distributed cen-
soring time from 0 months to the maximum censoring
time according to the cohort to which each case belonged.
For example, the individuals diagnosed in the first quarter
of 1995, the 951 cohort, were each assigned randomly a
censoring time from a uniform distribution ranging from
0 months to 23 months, the maximum censoring time for
this cohort. Similarly, the members of the 941 cohort
were each assigned a censoring time from a uniform dis-
tribution from 0 months to 35 months, the members of
the 931 cohort from 0 months to 47 months, and so forth.
The censoring time for each individual was taken to be the
minimum of this new censoring time or the original cen-
soring time defined as the time elapsed from their date of
diagnosis to December 31, 1996. By doing so, an artificial
censoring distribution is created with more uniform mass
over the possible times of death for each of the cohorts.
The reason to artificially censor the date arises from the
type of censoring distribution encountered in these data.
Specifically, subjects are enrolled within a narrow window
of time (three months) for each cohort and all subjects are
censored at the same chronological time. Thus, the cen-
soring distribution has all of its mass over a three month
period. The consequence of this is the potentially high
variability in the IPCW estimator for quantiles within the
support of censoring. By artificially censoring the data,
censoring is "spread" over a larger interval which reduces
the variability of estimates of survival at later quantiles.
The cost is that the variability of survival estimates of ear-
lier quantiles is increased by censoring originally uncen-
sored observations.
Prediction of median estimates of survival
Since our goal was to use early survival experiences to pre-
dict later survival, we examined the relation between the
early quantiles (i.e., 0.10, 0.15, 0.20, and 0.30 quantiles)
of the survival distribution and the 0.50 quantile. Assum-
ing a linear relationship, predicted median estimates were
calculated based on the estimation of the linear model by
entering the observed early quantile into the model. By
assuming a linear model, this implies that our method
only works so long as there is the same systematic shift in
the survival distribution over time. That is, if the early
quantile increases over time for a particular cohort, our
method works only if the later quantile increases as well.
The "true" quantiles of the survival distribution
The "true" quantiles (i.e., the best possible estimate of the
quantiles) of the survival distribution were assumed to be
the quantiles of survival estimated empirically from the
data using the IPCW estimator as of December 31, 2001.
This provided at least an additional five years of observa-
tion after the date of analysis upon which the early predic-
tions were made. In order to assess the performance of the
prediction method, the predicted median estimates using
our method were compared to these "true" medians (i.e.,
observed median estimates using data as of December 31,
2001) for the study sample.
Results
Deaths in HARS
The justification for using five years of follow-up as pro-
viding the "true" survival estimates (i.e., the length of fol-
low-up necessary for a cohort until the quantiles are
"stable" and the "true" quantiles are achieved for a partic-
ular cohort diagnosed with AIDS) is based upon empirical
data. Using the raw data as of December 31, 2001 (with
no artificial censoring imposed), the cumulative numbers
of deaths over ten years of follow-up for four cohorts were
determined (Table 1). Among the deaths that were known
to occur after ten years of follow up for the cohort of indi-
viduals diagnosed in 854 (n = 309 deaths reported as ofB
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Table 1: Cumulative number of deaths over a ten-year follow-up period for the 854, 874, 894, and 914 cohorts.
854 Cohort
n = 317
874 Cohort
n = 509
894 Cohort
n = 579
914 Cohort
n = 593
Date of Analysis Number of Deaths
Reported by
Date of Analysis
Cumulative
Deaths
% Cohort Number of Deaths
Reported by
Date of Analysis
Cumulative
Deaths
% Cohort Number of Deaths
Reported by
Date of Analysis
Cumulative
Deaths
% Cohort Number of Deaths
Reported by
Date of Analysis
Cumulative
Deaths
% Cohort
12/31/1985 0 0 0.0%
12/31/1986 0 0 0.0%
12/31/1987 196 196 61.8% 22 22 4.3%
12/31/1988 55 251 79.2% 153 175 34.4%
12/31/1989 14 265 83.6% 145 320 62.9% 31 31 5.4%
12/31/1990 15 280 88.3% 80 400 78.6% 182 213 36.8%
12/31/1991 20 300 94.6% 36 436 85.7% 143 356 61.5% 20 20 3.4%
12/31/1992 6 306 96.5% 24 460 90.4% 79 435 75.1% 203 223 37.6%
12/31/1993 0 306 96.5% 14 474 93.1% 48 483 83.4% 131 354 59.7%
12/31/1994 1 307 96.8% 8 482 94.7% 36 519 89.6% 86 440 74.2%
12/31/1995 2 309 97.5% 0 482 94.7% 14 533 92.1% 48 488 82.3%
12/31/1996 4 486 95.5% 9 542 93.6% 21 509 85.8%
12/31/1997 1 487 95.7% 3 545 94.1% 6 515 86.8%
12/31/1998 2 547 94.5% 3 518 87.4%
12/31/1999 0 547 94.5% 2 520 87.7%
12/31/2000 3 523 88.2%
12/31/2001 0 523 88.2%BMC Public Health 2007, 7:127 http://www.biomedcentral.com/1471-2458/7/127
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December 31, 1995 among n = 317 individuals identified
as part of this cohort), 83.6% of the cohort were known to
have died within four years and 88.3% were reported
within 5 years. On average, 80% or more of cohorts were
known to have died within four years of the identification
of the cohort. These results give empiric evidence that the
"true" quantiles of survival are those which are observed
five years after identification of the cohort and were our
basis for our decision to derive the "true" estimates using
data from December 2001.
Study sample using data as of December 31, 1996
There were 96,754 AIDS cases diagnosed between 1978
through 1996 and entered into the HARS database on or
before December 31, 1996. Of those, 84 cases (0.1%)
were excluded who were reported as having negative sur-
vival times (n = 1) or negative reporting times (n = 83).
After excluding 297 cases (0.31%) diagnosed prior to Jan-
uary 1, 1983 due to small sample sizes for each of these
cohorts, 96,373 (99.6%) of all AIDS cases diagnosed and
entered by December 31, 1996 were included in the anal-
ysis.
Survival quantiles according to the Inverse Probability of 
Censoring Weighted estimator
Figure 1 shows the 0.10, 0.15, 0.20, and the 0.50 quantiles
for cohorts estimated using the database as it would have
existed on December 31, 1996 (plotted on a log scale).
The median estimate appears to be increasing beginning
with the 864 cohort and again with the 904 cohort. There
are 11 cohorts (933 through 954 and 962) for which the
0.15 quantile could be estimated and the 0.50 quantile
could not be estimated using the IPCW estimator.
Observed Quantiles of the Survival Distribution, 1983–1996 (HARS Data as of December 31, 1996) Figure 1
Observed Quantiles of the Survival Distribution, 1983–1996 (HARS Data as of December 31, 1996).
Legend:
Black circle = 0.10 Quantile; Open diamond = 0.15 Quantile; Black square = 0.20 Quantile;
Open circle = 0.50 Quantile; AZT = zidovudine; PCP = Pneumocystis carinii pneumonia 
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Predicted median estimates based on the relation of the 
observed median estimates and the observed 0.15 
quantiles
Table 2 shows the observed 0.15 quantile (column A) and
the observed 0.50 quantile (column B) according to the
IPCW estimator as of December 31, 1996. From the
results of the linear regression analysis, a median could be
predicted for four cohorts (cohorts 933 through 942) for
which no median estimates had been observed as of
December 31, 1996 (column C) and compared to the true
median estimates five years later (column D). For the 933
cohort, the predicted median estimate was 34 months
based on the observed 0.15 quantile (the true median
based on the 2001 data was 32 months). For the 934
cohort, the predicted median estimate was 34 months
(the true median based on the 2001 data was 40 months).
The differences between the predicted median and the
"true" median increase as the cohorts get closer to the cen-
soring date, i.e., for cohorts 934, 941, and 942. A scatter-
plot of the observed 0.15 and 0.50 quantiles is given in
Figure 2.
A comparison of the predicted medians and the true
medians using other early quantiles of the survival distri-
bution as predictors in separate linear regression models
are shown graphically in Figure 3 (using the 0.10 and 0.15
quantiles as predictors) and Figure 4 (using the 0.20 and
0.30 quantiles as predictors).
A closer look at the predicted median survival estimates
according to the IPCW estimator (Table 2) shows that this
technique overestimated the median for earlier cohorts
(suggesting a steeper linear slope) and underestimated the
median for later cohorts (suggesting a less steep slope).
This would suggest that the relation between the 0.15
quantile and the 0.50 quantile while assumed to be linear
is changing over time. Thus, predicted median survival
estimates based on a model with an interaction between
the 0.15 quantile and calendar time was evaluated (Table
3). The inclusion of an interaction term with time yielded
a predicted median that was closer to the truth (in com-
parison to the model without an interaction term) for
three cohorts for which a median could not be observed
at the time the prediction was made (933, 941, and 942).
Median survival according to the Kaplan-Meier estimate 
of survival for four cohorts of AIDS cases
Our methodology enabled us to predict the median sur-
vival for four cohorts for which a median had not yet been
observed: the 933, 934, 941, and 942 cohorts. Using our
methodology, we estimated the median survival for the
cohort 933 would be 34 months as of December 31, 1996
(Tables 2 and 3). Using traditional techniques (i.e., using
the K-M estimator of survival), we would not have been
able to observe a median of 34 months for this cohort
until September 30, 2000 (almost four years later) (Addi-
tional File 1). Thus, our prediction method enabled us to
make a prediction for cohorts almost four years earlier
than it would be observed using traditional techniques.
For the cohort 934, we estimated the median survival
would be 34 months. As of December 31, 2001 (the clos-
ing date for our dataset), we still had not observed a
median of 34 months according to the K-M estimator. For
the 934 cohort, any median estimate would not be
observed using traditional methods until May 31, 1998,
17 months after the prediction was made (December 31,
1996) using our methodology (Additional File 2).
Predicted median estimates based on other dates of 
analyses
We also examined the performance of our prediction
method using two other dates of analyses other than
December 31, 1996. Prediction median estimates for data
as of December 31, 1992 and December 31, 1994 are pre-
sented in Additional Files 3 and 4 respectively.
Discussion
For cohorts of individuals who have been diagnosed
recently with AIDS, data exist relatively soon after diagno-
sis for estimating "early" survival quantiles (such as the
0.10, 0.15, 0.20 quantiles, etc.) but many years of addi-
tional observation must elapse before later quantiles can
be estimated accurately. The purpose of this study was to
determine if median survival could be predicted accu-
rately using earlier quantiles of survival distributions pro-
vided by AIDS surveillance data. Our approach for
predicting median survival consisted of two components:
(1) the estimation of quantiles of the survival distribution
using the IPCW estimator, and (2) the use of a linear
model to reflect the relationship between the early quan-
tile and the later quantile. The utility of such an approach
would allow early information to predict later unobserved
survival patterns in order to accurately identify changes in
population-based survival years before such changes are
observed. If accurate estimation could be achieved, this
approach could offer a method for researchers to estimate
the expected survival distribution after AIDS diagnosis (or
after many conditions for which surveillance databases
are maintained such as cancer). This approach enables
accurate predictions of changes in survival among HIV-
infected individuals like that observed in 1987 [3-5,12]
and more notably with the advent of the use of highly
active antiretroviral therapies [13-16].
The class of IPCW estimators has been developed in order
to improve more traditional techniques in situations
where these techniques may lead to biased estimates of
survival. IPCW estimators have been applied to many
types of survival problems such as correcting for non-
compliance and dependent censoring in the examinationBMC Public Health 2007, 7:127 http://www.biomedcentral.com/1471-2458/7/127
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Table 2: Predicted versus True 0.50 Quantiles using the 0.15 Quantile as a Predictor Variable.
Data as of December 31, 1996 Data as of December 31, 2001
Observed Quantiles
Cohort n largest follow-up
time (months)
0.15 (A) 0.50 (B) Predicted 0.50
Quantile† (C)
largest follow-up
time (months)
"True" 0.15
Quantile§ (D)
True 0.50
Quantile‡ (E)
Difference (C – E)
831 140 167 2 12 16 227 2 12 4
832 154 164 2 11 16 224 1 11 5
833 204 161 1 10 13 221 1 10 3
834 205 158 1 10 13 218 1 11 2
841 277 155 2 10 16 215 1 10 6
842 315 152 1 9 13 212 1 11 2
843 397 149 2 12 16 209 1 11 5
844 418 146 2 10 16 206 1 9 7
851 531 143 1 10 13 203 1 10 3
852 624 140 1 10 13 200 1 10 3
853 718 137 1 11 13 197 1 10 3
854 689 134 1 11 13 194 1 10 3
861 876 131 1 10 13 191 1 10 3
862 955 128 1 10 13 188 1 10 3
863 1113 125 1 11 13 185 1 11 2
864 1110 122 1 14 13 182 1 15 -2
871 1316 119 1 15 13 179 1 14 -1
872 1474 116 1 16 13 176 1 15 -2
873 1484 113 1 17 13 173 2 17 -4
874 1425 110 2 17 16 170 2 17 -1
881 1649 107 2 18 16 167 2 18 -2
882 1658 104 2 19 16 164 3 19 -3
883 1759 101 2 18 16 161 2 18 -2
884 1693 98 1 18 13 158 1 18 -5
891 1930 95 2 19 16 155 2 18 -2
892 2187 92 2 20 16 152 2 19 -3
893 2047 89 3 20 18 149 3 21 -3
894 1997 86 2 19 16 146 2 18 -2
901 2265 83 2 21 16 143 3 22 -6
902 2243 80 3 21 18 140 4 22 -4
903 2285 77 3 19 18 137 3 20 -2
904 2139 74 3 20 18 134 3 20 -2
911 2611 71 5 21 23 131 5 22 1
912 2543 68 4 23 21 128 4 23 -2
913 2845 65 4 23 21 125 4 23 -2
914 2930 62 5 24 23 122 5 24 -1
921 3227 59 7 27 29 119 8 27 2
922 2920 56 7 28 29 116 7 28 1
923 2971 53 7 28 29 113 7 27 2
924 3061 50 7 30 29 110 7 29 0
931 3264 47 9 32 34 107 9 31 3
932 2903 44 8 32 31 104 8 32 -1
933 2788 41 9 * 34 101 9 32 2
934 2624 38 9 * 34 98 9 40 -6
941 2766 35 8 * 31 95 9 46 -15
942 2518 32 7 * 29 92 8 80 -51BMC Public Health 2007, 7:127 http://www.biomedcentral.com/1471-2458/7/127
Page 8 of 13
(page number not for citation purposes)
of a beneficial treatment effect on survival [17] and non-
parametric survival estimation when death is reported
with delay [11], as in this study.
In this study, the 0.15 quantile of the survival distribution
predicted accurately the median survival for cohorts diag-
nosed before the third quarter of 1993. In addition, the
0.15 quantile of the survival distributions predicted accu-
rately the median survival in the short-term for two
cohorts (933 and 934) for which a median estimate could
not be estimated at the time of analysis (December 31,
1996). By using traditional methods (i.e., the K-M estima-
Scatterplot of the 0.15 Quantile and the Observed 0.50 Quantile as of December 31, 1996 Figure 2
Scatterplot of the 0.15 Quantile and the Observed 0.50 Quantile as of December 31, 1996.
Observed 0.15 Quantile (Months)
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943 2335 29 9 * 34 89 9 *
944 2203 26 9 * 34 86 8 *
951 2451 23 10 * 37 83 9 *
952 2245 20 11 * 39 80 10 *
953 1949 17 8 * 31 77 9 *
954 1860 14 10 * 37 74 9 *
961 1894 11 * * * 71 12 *
962 1488 8 5 * 23 68 16 *
963 1225 5 * * * 65 16 *
964 475 2 * * * 62 9 *
* denotes that the observed quantile could not be estimated from the data.
† The predicted 0.50 quantile is based on HARS data as of December 31, 1996.
§The true 0.15 quantile is based on HARS data as of December 31, 2001.
‡ The true 0.50 quantile is based on HARS data as of December 31, 2001.
Table 2: Predicted versus True 0.50 Quantiles using the 0.15 Quantile as a Predictor Variable. (Continued)BMC Public Health 2007, 7:127 http://www.biomedcentral.com/1471-2458/7/127
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tor) and without the use of our methodology, at least six
months of additional follow-up would be required to
observe any median survival estimate for the 933 cohort
and at least 45 months until the predicted median of 34
months (as predicted by our methodology) would be
observed for this cohort. This demonstrated that our
methodology not only provides an accurate estimate of
median survival, but an estimate of median survival long
before traditional approaches would allow.
The results of this study suggest that our methodology
yields an accurate prediction of median survival for
cohorts diagnosed at least three years earlier than the date
when the prediction is made. For example, the difference
between the predicted and the true median survival was ≤
6 months for the cohorts 933 and 934 but greater than 6
months for the cohorts 941 and 941 using data as of
December 31, 1996. The "true" median estimate (using
data as of December 31, 2001) according to the IPCW esti-
mator for the 942 cohort was estimated to be 80 months.
This may indeed be an early estimate of the median sur-
vival for this cohort and, as more data for this cohort
becomes available, this median estimate may decrease
over time like that observed with the K-M estimator (Addi-
tional File 1). This early estimate would greatly affect our
assessment of the accuracy of our predictions since we are
using this estimate as the "true" median survival. As a
result, if one applies this methodology now in the second
quarter of 2006, we could only expect to be able to predict
with accuracy the median survival for cohorts that were
Comparison of the Predicted† and True‡ 0.50 Quantiles using the 0.10 (top) and the 0.15 (bottom) Quantiles as Predictors Figure 3
Comparison of the Predicted† and True‡ 0.50 Quantiles using the 0.10 (top) and the 0.15 (bottom) Quantiles 
as Predictors.
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Legend:
† The predicted 0.50 quantile is based on HARS data as of December 31, 1996. 
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diagnosed in the second quarter of 2003 or earlier. This
methodology would not appear to work for cohorts diag-
nosed later than the second quarter of 2003.
The ability of the method, however, to accurately predict
median survival in the short-term based on historical data
is greatly influenced by three factors: (1) the variability of
the estimates of the various quantiles of the survival dis-
tribution, (2) the assumption that the relation between
the early quantile and the later quantile (median) can be
represented by a linear model, and (3) this relation will
remain the same in the short-term.
The estimates of the various quantiles of the survival dis-
tribution are affected greatly by two sources of bias: delays
in diagnosis and delays in death reports. The fact that
patients who were in HARS as of a particular date of anal-
ysis were included in the study sample obviously excluded
those who were diagnosed before this date of analysis but
were reported sometime after. Delays in diagnosis affect
the estimates of survival by introducing additional indi-
viduals into each of the cohorts and, depending on their
individual survival times, may affect the observed quan-
tiles of the survival distribution. It is unclear how such
individuals would affect the estimates of survival, but this
potential for bias was eliminated by only including those
who were reported by a fixed data of analysis (e.g., Decem-
ber 31, 1996) in order to mimic the "real world" situation
in which only those patients currently entered into a data-
base are available for analysis. This should not detract
from the utility of the estimation procedure since the pre-
dicted medians were compared with additional data five
Comparison of the Predicted† and True‡ 0.50 Quantiles using the 0.20 (top) and the 0.30 (bottom) Quantiles as Predictors Figure 4
Comparison of the Predicted† and True‡ 0.50 Quantiles using the 0.20 (top) and the 0.30 (bottom) Quantiles 
as Predictors.
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Legend: 
† The predicted 0.50 quantile is based on HARS data as of December 31, 1996. 
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Table 3: Predicted versus True 0.50 Quantiles using the 0.15 Quantile as a Predictor Variable based on a linear model with an 
interaction term.
Data as of December 31, 1996 Data as of December 31, 2001
Observed Quantiles
Cohort n largest follow-up
time (months)
0.15 (A) 0.50 (B) Predicted 0.50
Quantile† (C)
largest follow-up
time (months)
"True" 0.15
Quantile§ (D)
True 0.50
Quantile‡ (E)
Difference (C – E)
831 140 167 2 12 9 227 2 12 -3
832 154 164 2 11 10 224 1 11 -1
833 204 161 1 10 9 221 1 10 -1
834 205 158 1 10 9 218 1 11 -2
841 277 155 2 10 11 215 1 10 1
842 315 152 1 9 10 212 1 11 -1
843 397 149 2 12 12 209 1 11 1
844 418 146 2 10 12 206 1 9 3
851 531 143 1 10 11 203 1 10 1
852 624 140 1 10 11 200 1 10 1
853 718 137 1 11 12 197 1 10 2
854 689 134 1 11 12 194 1 10 2
861 876 131 1 10 13 191 1 10 3
862 955 128 1 10 13 188 1 10 3
863 1113 125 1 11 13 185 1 11 2
864 1110 122 1 14 14 182 1 15 -1
871 1316 119 1 15 14 179 1 14 0
872 1474 116 1 16 14 176 1 15 -1
873 1484 113 1 17 15 173 2 17 -2
874 1425 110 2 17 16 170 2 17 -1
881 1649 107 2 18 17 167 2 18 -1
882 1658 104 2 19 17 164 3 19 -2
883 1759 101 2 18 17 161 2 18 -1
884 1693 98 1 18 16 158 1 18 -2
891 1930 95 2 19 18 155 2 18 0
892 2187 92 2 20 18 152 2 19 -1
893 2047 89 3 20 20 149 3 21 -1
894 1997 86 2 19 19 146 2 18 1
901 2265 83 2 21 19 143 3 22 -3
902 2243 80 3 21 21 140 4 22 -1
903 2285 77 3 19 21 137 3 20 1
904 2139 74 3 20 22 134 3 20 2
911 2611 71 5 21 24 131 5 22 2
912 2543 68 4 23 23 128 4 23 0
913 2845 65 4 23 24 125 4 23 1
914 2930 62 5 24 25 122 5 24 1
921 3227 59 7 27 28 119 8 27 1
922 2920 56 7 28 28 116 7 28 0
923 2971 53 7 28 28 113 7 27 1
924 3061 50 7 30 29 110 7 29 0
931 3264 47 9 32 31 107 9 31 0
932 2903 44 8 32 31 104 8 32 -1
933 2788 41 9 * 32 101 9 32 0
934 2624 38 9 * 32 98 9 40 -8
941 2766 35 8 * 32 95 9 46 -14BMC Public Health 2007, 7:127 http://www.biomedcentral.com/1471-2458/7/127
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years after the prediction was made using only those
patients who were selected in the original study sample.
In addition, delays in the reporting of death can bias esti-
mates of survival if one assumes that a case is alive if a
death date has not been reported. In this study, the use of
the IPCW estimator is an attempt to mitigate the potential
for bias in estimating survival after an AIDS diagnosis due
to reporting delays of death. This estimator adjusts the
estimates of survival for a given cohort to account for
delays in death reports, provided that the delay of death
report distribution is known. The bias introduced by fail-
ing to account for delays in death reporting when estimat-
ing survival after an AIDS diagnosis has already been
established [11].
For simplicity, the prediction method assumed that the
early quantile such as the 0.15 quantile, a representation
of the "early"' survival experience was linearly related to
the median of the survival estimate, the "later survival
experience". Higher-dimensional models were explored
but did not improve the predictive ability (data not
shown). In assuming a linear relationship and extrapolat-
ing the observed relationship to the future, an additional
assumption made was that this relationship would
remain as observed in the past, at least in the short-term.
Validation from the more recent cohorts (i.e., the 933 and
934 cohorts) confirms that the linear model accurately
predicts median survival in the short-term, but may not
perform well for all cohorts (e.g., the 941 and 942
cohorts). Assuming that HAART first became available
with the approval of Saquinavir (hard-gel) in December
1995, the 941 and 942 cohorts would have been intro-
duced to HAART earlier after diagnosis (21 months for the
941 cohort and 18 months for the 942 cohort) in compar-
ison to the 933 and 934 cohorts (27 months and 24
months respectively). When comparing survival across
different cohorts diagnosed over time, we would expect
the later cohorts to demonstrate a shift in survival, thus
violating any observed linear relationships between ear-
lier quantiles and later quantiles observed in the past.
Conclusion
This investigation suggests that this approach to survival
estimation accurately predicted subsequent survival expe-
rience observed in two of these cohorts (the 933 and 934
cohorts). It is notable that the technique did not perform
well during a period of rapid increase in AIDS survival that
is not unlike the presently observed increases in survival
influenced by current advances in therapy. However, the
performance of the methodology before the introduction
of HAART suggests that this methodology may work well
in a time of more gradual improvement in survival with
antiretroviral treatment. This technique may also have
application in other areas of research (e.g. cancer surveil-
lance) where population changes in survival have been
observed and should be validated using additional data.
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942 2518 32 7 * 31 92 8 80 -49
943 2335 29 9 * 33 89 9 *
944 2203 26 9 * 34 86 8 *
951 2451 23 10 * 35 83 9 *
952 2245 20 11 * 36 80 10 *
953 1949 17 8 * 34 77 9 *
954 1860 14 10 * 36 74 9 *
961 1894 11 * * * 71 12 *
962 1488 8 5 * 31 68 16 *
963 1225 5 * * * 65 16 *
964 475 2 * * * 62 9 *
* denotes that the observed quantile could not be estimated from the data.
† The predicted 0.50 quantile is based on HARS data as of December 31, 1996.
§The true 0.15 quantile is based on HARS data as of December 31, 2001.
‡ The true 0.50 quantile is based on HARS data as of December 31, 2001.
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